TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
PACB

Pacific Biosciences of California

Healthcare · Medical Devices

2.70$ +0.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Pacific Biosciences of California (PACB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 752 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PACB
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
151 138 136 178 158 144 157 137 183 170 186 171 146 148 235 214 300 414 1,253 1,246 2,034 2,007 1,937 1,876 1,819 1,767 1,896 1,848 1,898 1,746 1,670 1,509 1,450 1,260 861 825 803 784 782 752
122 109 88 133 114 102 116 96 144 132 113 99 77 81 170 151 240 356 1,196 1,189 1,130 1,101 1,029 970 914 852 981 936 882 742 677 628 584 496 445 413 394 375 370 339
23 17 29 36 26 63 25 23 116 19 38 30 33 30 69 43 69 82 932 460 425 461 429 310 304 325 354 209 386 180 77 100 78 55 59 55 56 64 56 61
87 72 56 103 84 63 79 63 116 102 83 67 49 49 143 120 209 319 1,160 1,144 1,080 1,044 963 899 834 772 875 830 768 632 562 510 471 390 343 315 299 280 276 237
12 16 10 9.5 8.9 13 8.5 7.4 6.4 8.6 7.3 12 10.0 15 7.3 11 12 17 13 20 24 24 28 27 23 19 30 24 30 37 30 32 29 28 32 32 31 35 29 31
16 16 15 17 18 23 26 23 20 18 20 17 15 13 16 17 16 14 16 18 18 25 30 36 43 50 62 68 68 57 67 69 66 59 54 54 53 49 51 61
14 15 42 40 40 38 37 36 34 34 34 33 65 30 29 28 27 25 24 54 77 79 36 81 81 81 41 40 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – 412 410 410 410 410 410 410 410 464 462 462 369 369 318 318 318 318 318 318 318
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – 411 411 411 411 410 410 410 410 462 457 450 443 436 390 18 17 16 15 14 13
52 53 66 62 56 58 54 52 51 56 91 95 95 93 174 172 171 78 972 988 1,193 1,216 1,202 1,194 1,192 1,204 1,204 1,206 1,135 1,045 1,021 1,017 997 754 769 764 767 779 780 785
32 34 35 36 30 22 25 22 16 20 45 49 51 49 132 131 130 39 34 45 56 72 61 84 82 263 266 271 184 95 73 78 60 66 67 60 63 54 65 69
16 17 3.1 2.6 2.9 6.3 10 11 3.6 6.3 22 22 23 20 4.0 4.1 4.2 4.3 4.4 4.6 7.1 9.3 8.1 8.4 8.6 11 9.0 9.2 9.5 10 9.8 12 11 10 2.4 0.7 3.6 0.4 0.3 1.4
8.3 8.4 8.2 6.5 8.6 9.1 8.6 4.2 6.0 6.7 8.7 8.0 8.1 8.4 4.2 7.4 5.4 3.6 3.5 4.8 5.0 11 18 13 13 12 17 17 16 15 21 17 12 17 14 15 16 21 14 19
16 16 13 10 10 14 14 14 14 15 45 – – 16 – – – – 896 896 896 896 896 896 897 897 897 892 892 892 893 893 893 647 646 646 645 645 644 644
99 85 69 116 101 86 103 85 132 114 95 76 51 55 60 41 129 335 281 258 841 791 735 682 627 563 692 642 764 701 649 493 453 507 92 61 36 5.3 2.4 -33
-769 -788 -811 -837 -859 -880 -904 -926 -951 -982 -1,012 -1,037 -1,066 -1,066 -1,065 -1,088 -1,112 -1,037 -1,124 -1,165 -1,149 -1,218 -1,300 -1,371 -1,448 -1,532 -1,620 -1,690 -1,757 -1,839 -1,917 -2,091 -2,151 -2,149 -2,575 -2,617 -2,655 -2,695 -2,704 -2,748
92 93 93 97 116 116 124 132 135 149 151 153 153 153 156 154 167 204 195 199 215 221 222 224 225 226 242 250 255 267 270 272 273 307 297 300 301 302 306 311

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?